IL188478A0
(en )
2008-04-13
Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists
ZA200800353B
(en )
2008-12-31
Pyrazine derivatives useful as adenosine receptor antagonists
AP2006003840A0
(en )
2006-12-31
Indole-2-carboxamidine derivatives as NMDA receptor antagonists
ZA200708028B
(en )
2008-08-27
Acetylenyl-pyrazolo-pyrimidine derivatives as mGluR2 antagonists
GB0509275D0
(en )
2005-06-15
Synthetic receptor
EP2058304A4
(en )
2012-10-10
P2x4 receptor antagonist
IL184816A0
(en )
2007-12-03
2-phenyl-indoles as prostaglandin d2 receptor antagonists
AP2007004047A0
(en )
2007-06-30
Substituted triazole derivatives as oxtocin antagonists
AP2008004441A0
(en )
2008-04-30
Piperdin-4-ylpyrazin-2-ylamine derivatives as fastdissociating dopamine 2 receptor antagonists
IL186188A0
(en )
2008-01-20
Pyrimidindione derivatives as prokineticin 2 receptor antagonists
IL190152A0
(en )
2008-08-07
Indane derivatives as mch receptor antagonists
AP1983A
(en )
2009-03-24
Carboxamide derivatives as muscarinic receptor antagonists
IL192308A0
(en )
2009-02-11
Oxazoloisoquinoline derivatives as thrombin receptor antagonists
PT1912976E
(en )
2009-01-07
Indol-3-yl-carbonyl-piperidin-benzoimidazole derivatives as v1a receptor antagonists
GB0509276D0
(en )
2005-06-15
Synthetic receptor
HUP0501169A3
(en )
2008-03-28
New phenantridine derivatives as selective bradykinin b1 receptor antagonists
ZA200802339B
(en )
2009-10-28
Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
ZA200903496B
(en )
2010-03-31
Spiro-piperidine derivatives as via receptor antagonists
GB0525029D0
(en )
2006-01-18
Receptor Antagonist
ZA200800516B
(en )
2008-12-31
Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as V1a receptor antagonists
GB0516946D0
(en )
2005-09-28
Receptor
GB0516617D0
(en )
2005-09-21
EP2 Receptor antagonists
GB0522484D0
(en )
2005-12-14
Receptor
GB0522394D0
(en )
2005-12-14
Receptor
GB0522077D0
(en )
2005-12-07
Receptor